Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum, Juan L. Vivero‐Escoto
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114357-114357
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
Youyou Li, Jing Liu, Yimei Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 44
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives
Wenzhao Liu, Zhanjun Ma, Yonggang Wang, et al.
Bioactive Materials (2022) Vol. 23, pp. 274-299
Open Access | Times Cited: 66
miRNAs orchestration of gallbladder cancer – Particular emphasis on diagnosis, progression and drug resistance
Reem K. Shahin, Mohamed A. Elkady, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154684-154684
Closed Access | Times Cited: 34
Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases
Hiroshi Yukawa, Kazuhide Sato, Yoshinobu Baba
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114863-114863
Open Access | Times Cited: 25
Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
Xin Gu, Tamara Minko
Cancers (2024) Vol. 16, Iss. 8, pp. 1589-1589
Open Access | Times Cited: 11
Recent advancements in Irinotecan-loaded nanomaterials as a smart drug delivery system for cancer therapy: A state-of-art-review
Sonia Fathi‐karkan, Maimoona Qindeel, Rabia Arshad, et al.
Inorganic Chemistry Communications (2024) Vol. 161, pp. 112028-112028
Closed Access | Times Cited: 10
Harnessing nanotechnology for cancer treatment
Jiajun Zhu, H. H. Lee, Rong Huang, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access | Times Cited: 1
Two-Stage SN38 Release from a Core–Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade
Xiaomin Jiang, Morten J. Lee, Junjie Xia, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 21417-21430
Open Access | Times Cited: 37
Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications
Rui Huang, Cristina‐Maria Hirschbiegel, Victor Lehot, et al.
Advanced Materials (2023) Vol. 36, Iss. 10
Closed Access | Times Cited: 16
Drug Delivery Strategies for the Treatment of Pancreatic Cancer
Oluwabukunmi Olajubutu, Omotola D. Ogundipe, Amusa S. Adebayo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1318-1318
Open Access | Times Cited: 16
Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy
Youyou Li, Jing Liu, Ralph R. Weichselbaum, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
Zhide Liu, Yin-Hao Shi, Qiong‐Cong Xu, et al.
Cancer Letters (2024) Vol. 585, pp. 216640-216640
Open Access | Times Cited: 6
Unleashing a Dual‐Warhead Nanomedicine to Precisely Sensitize Immunotherapy for Pancreatic Ductal Adenocarcinoma
Di Zhang, Qingxu Song, Wenjuan Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 6
Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy
Shilin Zhang, Haoyu You, Hongrui Fan, et al.
Nano Letters (2025)
Closed Access
Localized paclitaxel delivery using a novel hyaluronic acid-coated fibrous carrier produced via needle-less electrospinning
Daniela Lubasová, Mireia Mayoral Safont, Emmet McCormack
Journal of Industrial Textiles (2025) Vol. 55
Open Access
Biomembrane‐coated nanosystems as next‐generation delivery systems for the treatment of gastrointestinal cancers
Joana Lopes, Daniela Lopes, Mahzad Motallebi, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Overcoming Obstacles: The Role of Lipid Nanocarriers in Therapeutic Approaches for Pancreatic Cancer
Md Sadique Hussain, Bhupendra G. Prajapati, Sonu Gandhi, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Co-delivery of three synergistic chemotherapeutics in a core-shell nanoscale coordination polymer for the treatment of pancreatic cancer
Xiaomin Jiang, Morten J. Lee, Taokun Luo, et al.
Biomaterials (2023) Vol. 301, pp. 122235-122235
Open Access | Times Cited: 10
Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach
Miguel Pereira‐Silva, Luis Díaz‐Gómez, Bárbara Blanco‐Fernandez, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124529-124529
Open Access | Times Cited: 3
Nanomedicines enhance minimally invasive therapy of pancreatic cancer
Peipei Yang, Xin Zhi, Yunxue Xu, et al.
Nano Today (2023) Vol. 51, pp. 101891-101891
Closed Access | Times Cited: 7
Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer
Zhaokai Zhou, Yuyuan Zhang, Jing Li, et al.
Cellular Signalling (2023) Vol. 109, pp. 110774-110774
Open Access | Times Cited: 7
Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 7
Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression
Marilyn Kaul, Ahmed Yousuf Sanin, Wenjie Shi, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 793-806
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top